Canada Pension Plan Investment Board’s Esperion Therapeutics ESPR Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97.6K	Sell	30,900 -77,200	-71%	-$216K	﹤0.01%	1671
2026 Q1	$296K	Buy	+108,100	New	+$342K	﹤0.01%	1421
2019 Q4	–	Sell	-10	Closed	–	–	1432
2019 Q3	$0	Sell	10 -54,200	-100%	-$2.15M	﹤0.01%	1217
2019 Q2	$2.52M	Buy	54,210 +53,897	+17,219%	+$2.53M	0.01%	907
2019 Q1	$13K	Buy	+313	New	+$14K	﹤0.01%	1405
2018 Q3	–	Sell	-8,500	Closed	-$333K	–	1276
2018 Q2	$333K	Buy	+8,500	New	+$429K	﹤0.01%	1126

Other funds holding ESPR

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Canada Pension Plan Investment Board's ESPR Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Esperion Therapeutics (ESPR) stake by 71% in Q2 2026, selling an estimated $216K and leaving 30,900 shares worth $97.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1671.

Canada Pension Plan Investment Board first reported a position in ESPR in Q2 2018 and has held it in 6 quarters since. The position peaked at $2.52M in Q2 2019. 191 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

Canada Pension Plan Investment Board held 30,900 shares of Esperion Therapeutics worth $97.6K as of Q2 2026.
Canada Pension Plan Investment Board sold 77,200 Esperion Therapeutics shares in Q2 2026, an estimated $216K.
Esperion Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1671 holding.
Canada Pension Plan Investment Board first reported a position in Esperion Therapeutics in Q2 2018 and has held it in 6 quarters since.
Canada Pension Plan Investment Board's Esperion Therapeutics position peaked at $2.52M in Q2 2019.
191 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.